Navigation Links
AgeLab Director Brings Wisdom to Aging Brains
Date:4/16/2008

SAN FRANCISCO, April 16 /PRNewswire/ -- Posit Science Corporation, the leading provider of scientifically proven brain fitness programs, announced today that Joseph Coughlin, Ph.D., the founder and Director of MIT's AgeLab, has joined its advisory board. Dr. Coughlin was recently named by the Wall Street Journal as one of the 12 people who will most affect your retirement. He will assist Posit Science in its efforts to help people improve performance in driving, health and mobility.

The MIT AgeLab conducts cutting edge research that explores how science and technology can be applied today to help aging adults live better. Dr. Coughlin's projects at the Age Lab include extensive work in driving, mobility and health -- all of which are targeted for improvement through use of a new visual training program from Posit Science.

"Health has always been a desire in old age; however, the boomers have translated desire into demand -- demand for information, tools, and ultimately the control to age well," Dr. Coughlin said. A new generation of research-driven technology promises to provide older adults with the capacity to take control of how they will live in later life, not just how long they will live."

"Joe Coughlin is a trail blazer in what we can do to improve aging by applying lab breakthroughs into everyday life," said Jeff Zimman, CEO of Posit Science. "That commitment matches our core mission which is to get the science out of the labs and into the hands of people who can get more of what they want out of life. We will benefit greatly from his advice and experience."

Posit Science develops clinically proven software programs that improve the speed and accuracy of mental processing, memory and other cognitive functions. The company's programs have been shown to be effective in numerous studies and in more than 30 published journal articles.

Every 7 seconds a Baby Boomer turns 62, Coughlin noted. "As our population ages, we need the best science we can offer to enable older people to lead long, rich and fulfilling lives," Dr. Coughlin said. "The final stage of translational research falls to companies, like Posit Science, to create the markets that translate science into innovations in living."

Other members of Posit Science's Special Advisory Board include: Jennie Chin Hansen, former director of On Lok, Inc. and president-elect of AARP; Avram Miller, former business development leader at Intel; Lloyd Morrisett, Ph.D., co-founder of the Sesame Street Workshop; Jerry Swartz, Ph.D., co-founder of Symbol Technologies and of the Swartz Foundation for Computational Neuroscience; Arthur White, Vice Chairman of Yankelovich,; David Wolfe, co-author of Ageless Marketing; and Steve Zaleznick, CEO of the Longevity Alliance and former President and CEO of AARP Services, Inc. In addition, the Posit Science Scientific Advisory Board includes more than 40 prominent brain scientists from leading universities around the world.

ABOUT POSIT SCIENCE CORPORATION

Posit Science is the leading provider of clinically validated brain health products and services. The company works with more than 50 scientists from prestigious universities to design and test its computer-based programs. More than 30 published studies show that the company's patented technologies significantly increase processing speed, improve memory, and enhance the quality of everyday life. Posit Science has received numerous grants and awards from groups such as the National Institutes of Health (NIH), the American Society for Aging (ASA), and CNBC. For more information visit http://www.PositScience.com or call 1-800-514-3961.


'/>"/>
SOURCE Posit Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Otter Tail Corporation Holds 2008 Annual Meeting: Shareholders Elect Directors; Board Declares Quarterly Dividend
2. HHS Names First Director of the Biomedical Advanced Research Development Authority
3. Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors
4. Muneo Takashi Named Chief Executive Director of Japans Midwest Trade Office
5. Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services
6. Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
7. Nutrition 21 Elects Mark H. Stenberg to Board of Directors
8. Hyperion Therapeutics Elects Lota Zoth to Board of Directors
9. Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCaths Board of Directors
10. Global Action Board of Directors Announces Addition of Newest Member, Robert Hernreich
11. American Pacific Director, Fred D. Gibson, Jr., Continues Funding Georgia Tech Endowment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
(Date:1/20/2017)... Miami, Florida (PRWEB) , ... January 20, 2017 , ... ... in head lice cases in families with school-aged children since the holiday season. ... spend the holidays with their families, sharing hugs and taking photos, which is the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... its sugar-free alternative VW+ 002. The drinks have been produced in collaboration with ... to perform during your workout. , After a successful launch in Sweden last ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: